The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, ...

As a registered dietitian in Eastern Oregon, I work with patients living with obesity. The Food and Drug Administration has ...

US price cuts, Medicare expansion, and new oral GLP-1 approvals reshape the competitive outlook for weight-loss drugs.

The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and compounded GLP-1s. The best weight ...

AMGN's MariTide enters late-stage obesity trials with monthly dosing but faces rising competition as Eli Lilly and Novo ...

Earlier this week, the FDA approved Eli Lilly and Company’s LLY rival Novo Nordisk’s NVO oral version of the obesity drug ...

While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them ...

Eli Lilly and Company today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study evaluated orforglipron, an investigational, once-daily oral small molecule ...

Dividend growth investing builds long-term wealth for retirement by focusing on companies that consistently increase payouts.

Incannex Healthcare received fast track designation from the Food and Drug Administration for its IHL-42X treatment of obstructive sleep apnea. The designation grants the IHL-42X program more frequent ...

Experts say a promising sleep apnea pill may soon transform how millions manage the condition, pending FDA approval. Judge Delivers Final Blow to Trump Case Donald Trump mocked in Venezuela media ...

MELBOURNE, Australia and NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, ...